Method of treating benign hypertrophy of the prostate

A method of improving symptoms of benign hypertrophy of the prostate in a patient, comprising:

• placing an attenuation device percutaneously into the bladder;
• and
• positioning a compressible portion of the device and a compressible medium within the bladder of the patient;
• wherein the device inhibits a decrease in compliance of the bladder wall as a consequence of the benign hypertrophy of the prostate while maintaining the compressible medium entirely within the bladder when the device is exposed to increased pressure in the bladder.

A method of treating a patient with benign hypertrophy of the prostate, comprising the steps of:

• positioning a compressible attenuation device, moveable from an introduction configuration to an implanted configuration, completely within the bladder while in the introduction configuration;
• transforming the attenuation device within the bladder to the second configuration;
• and
• attenuating an increase in pressure within the bladder by reversibly reducing the volume of the attenuation device in response to the pressure, while the attenuation device is completely within the bladder.

A method of improving symptoms of benign hypertrophy of the prostate in a patient, comprising:

• placing an attenuation device into the bladder;
• and
• positioning a compressible portion of the device and a compressible medium within the bladder of the patient;
• wherein the device inhibits a decrease in compliance of the bladder wall as a consequence of the benign hypertrophy of the prostate while maintaining the compressible medium entirely within the bladder when the device is exposed to increased pressure in the bladder.